Dezhou Wutai Pharmaceutical Technology Co., Ltd.

To compare the differences in the extent and rate of absorption of indobufen tablets (specification: 0.2g) produced by Shandong Lusheng Pharmaceutical Co., Ltd. and indobufen tablets (specification: 0.2g, trade name: Ibustrin ®) licensed and produced by Pfizer Italia S.r.l. in healthy people under fasting and postprandial administration conditions. To evaluate the safety and tolerability of the two preparations and provide a basis for the registration application of the test preparation.